eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026

世界のe臨床ソリューション市場予測(~2026):臨床試験フェーズ別、製品別、配信別、エンドユーザー別

◆タイトル:eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026
◆商品コード:HIT2208
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年9月16日
◆ページ数:225
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社はe臨床ソリューションの世界市場規模が2021年83億ドルから2026年154億ドルまで、年平均13.3%成長すると予想しています。本調査レポートでは、世界のe臨床ソリューション市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品別(電子データキャプチャ・臨床データ管理システム、臨床試験管理システム、臨床分析プラットフォーム、ランダム化・試験供給管理、臨床データ統合プラットフォーム)分析、配信別(Webホスト(オンプレミス)ソリューション、ライセンスエンタープライズ(オンプレミス)ソリューション、クラウド(SAAS)ソリューション)分析、臨床試験フェーズ別(フェーズI臨床試験、フェーズII臨床試験、フェーズIII臨床試験、フェーズIV臨床試験)分析、エンドユーザー別(製薬・バイオ医薬品会社、委託研究、コンサルティングサービス会社、医療機器メーカー、病院)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・e臨床ソリューションの世界市場規模:製品別(電子データキャプチャ・臨床データ管理システム、臨床試験管理システム、臨床分析プラットフォーム、ランダム化・試験供給管理、臨床データ統合プラットフォーム)
・e臨床ソリューションの世界市場規模:配信別(Webホスト(オンプレミス)ソリューション、ライセンスエンタープライズ(オンプレミス)ソリューション、クラウド(SAAS)ソリューション)
・e臨床ソリューションの世界市場規模:臨床試験フェーズ別(フェーズI臨床試験、フェーズII臨床試験、フェーズIII臨床試験、フェーズIV臨床試験)
・e臨床ソリューションの世界市場規模:エンドユーザー別(製薬・バイオ医薬品会社、委託研究、コンサルティングサービス会社、医療機器メーカー、病院)
・e臨床ソリューションの世界市場規模:地域別
・競争状況
・企業情報

“The global eClinical Solutions market is projected to reach USD 15.4 billionby 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%.”
Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market.

“Cloud-based (SaaS) segment is projected to record the highest CAGR.”
Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) are fueling the growth of the cloud-based eClinical solutions market.

“Phase III clinical trials is expected to register the highest growth during the forecast period.”
Based on clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.

“CROs segment is estimated to record the highest CAGR in the forecast period.”
Based on end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.

“North America To Witness Significant Growth From 2021 To 2026.”
In 2020, North America commanded the largest share of the eClinical solutions market.Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 33%, Tier 2 – 42%, and Tier 3 – 18%
• By Designation: C-level – 29%, Director-level – 23%, and Others – 48%
• By Region: North America – 35%, Europe – 30%, APAC –26%, Rest of the World –9%

Some of the prominent players in this market are Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US)

Research Coverage
This report describes and studies the eClinical Solutions market based on product, delivery mode, clinical trials phases, end users and region. It provides detailed information regarding the major factors influencing the growth of this market and the factors impacting market dynamics. The report includes in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments (mergers, acquisitions, partnerships, collaborations, etc.), and key business strategies.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】



★調査レポート[世界のe臨床ソリューション市場予測(~2026):臨床試験フェーズ別、製品別、配信別、エンドユーザー別] ( eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026 / HIT2208) 販売に関する免責事項
[世界のe臨床ソリューション市場予測(~2026):臨床試験フェーズ別、製品別、配信別、エンドユーザー別] ( eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026 / HIT2208) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆